DeepCurrents Investment Group’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-152,109
Closed -$19.9M 217
2021
Q3
$19.9M Sell
152,109
-105,225
-41% -$13.8M 0.59% 51
2021
Q2
$35.4M Buy
257,334
+9,838
+4% +$1.35M 1.06% 27
2021
Q1
$32.3M Buy
247,496
+19,167
+8% +$2.31M 1.11% 24
2020
Q4
$25.6M Buy
228,329
+45,405
+25% +$4.3M 0.67% 35
2020
Q3
$14.4M Sell
182,924
-279
-0.2% -$22.8K 0.49% 42
2020
Q2
$13.2M Buy
183,203
+13,396
+8% +$932K 0.48% 43
2020
Q1
$9.72M Buy
169,807
+134,677
+383% +$12.4M 0.47% 51
2019
Q4
$3.93M Sell
35,130
-29,622
-46% -$3.16M 0.18% 65
2019
Q3
$6.23M Buy
64,752
+15,023
+30% +$1.41M 0.42% 51
2019
Q2
$4.26M Buy
+49,729
New +$4.09M 0.36% 56

Other funds holding CNMD

DeepCurrents Investment Group's CNMD Position: Q4 2021 in Review

DeepCurrents Investment Group sold out of CONMED (CNMD) in Q4 2021, closing a stake of 152,109 shares — an estimated $19.9M sold.

DeepCurrents Investment Group first reported a position in CNMD in Q2 2019 and held it in 10 quarters. The position peaked at $35.4M in Q2 2021. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2021.

  • DeepCurrents Investment Group reported no remaining CONMED position as of Q4 2021 after selling out during the quarter.
  • DeepCurrents Investment Group sold 152,109 CONMED shares in Q4 2021, an estimated $19.9M.
  • DeepCurrents Investment Group first reported a position in CONMED in Q2 2019 and held it in 10 quarters.
  • DeepCurrents Investment Group's CONMED position peaked at $35.4M in Q2 2021.
  • 265 funds tracked by Wall St. Rank held CONMED as of Q4 2021.

Based on DeepCurrents Investment Group's 13F filing for Q4 2021, filed 14 Feb 2022.